Complex Evaluation of Antioxidant Capacity of Milk Thistle Dietary Supplements
Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic
Typ dokumentu časopisecké články
Grantová podpora
16-06008S
Czech Science Foundation
692195
European Union Horizon 2020 research and innovation Programme
CZ.2.16/3.1.00/21537 and CZ.2.16/3.1.00/24503
Operational Programme Prague-Competitiveness
NPU I (LO1601) MSMT-43760/2015
Czech National Program of Sustainability
AZV 16-27317A and RVO-VFN64165/2017
Czech Ministry of Health
PubMed
31426591
PubMed Central
PMC6720444
DOI
10.3390/antiox8080317
PII: antiox8080317
Knihovny.cz E-zdroje
- Klíčová slova
- ABTS, DPPH, ORAC, U-HPLC-HRMS/MS, antioxidant activity, cellular antioxidant assay, milk thistle, silymarin,
- Publikační typ
- časopisecké články MeSH
Numerous in vitro assays are used to characterize the antioxidant properties of natural-based matrices. However, many of them generate contradictory and non-compliant results. In our study, we focused on the characterization of traditionally used biochemical (2,2'-azino-bis-(3-ethylbenzothiazoline-6 sulfonic acid) (ABTS), Oxygen Radical Absorption Capacity (ORAC), and 2,2-diphenyl-1-picrylhydrazyl (DPPH)) and cellular (CAA) antioxidant tests on a broad set of milk thistle dietary supplements containing silymarin. In addition to 26 commercially available preparations, also the natural silymarin extract available from Sigma Aldrich, St. Louis, MI, USA, and a model mixture of pure flavonoid/flavonolignans mimicking the silymarin composition were investigated as control samples. Significant differences in the antioxidant capacity of the supplements were observed. Unlike the DPPH, the results of the ABTS and ORAC methods correlated with the silymarin components determined by U-HPLC-HRMS/MS. The responses in CAA were considerably lower than in other assays. Silymarin exhibited a significantly higher antioxidant capacity than the artificially prepared flavonoid/flavonolignans mixture in all tests, indicating possible presence of other antioxidants of natural origin. The follow-up U-HPLC-HRMS/MS screening revealed the presence of tens of non-silymarin compounds with reported antioxidant activity (not only in the silymarin extract, but also in the milk thistle preparations). The sum of the total phenolics and the sum of the simple phenolics correlated with CAA results more than silymarin.
Zobrazit více v PubMed
Moon J.-K., Shibamoto T. Antioxidant assays for plant and food components. J. Agric. Food Chem. 2009;57:1655–1666. doi: 10.1021/jf803537k. PubMed DOI
Alves C.Q., David J.M., David J.P., Bahia M.V., Aguiar R.M. Methods for determination of in vitro antioxidant activity for extracts and organic compounds. J. Food Sci. Tech. Mysore. 2010;33:2202–2210. doi: 10.1590/S0100-40422010001000033. DOI
Kim N.-C., Graf T.N., Sparacino C.M., Wani M.C., Wall M.E. Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum) Org. Biomol. Chem. 2003;1:1684–1689. doi: 10.1039/b300099k. PubMed DOI
Skottová N., Vecera R., Urbanek K., Vana P., Walterová D., Cvak L. Effects of polyphenolic fraction of silymarin on lipoprotein profile in rats fed cholesterol-rich diets. Pharmacol. Res. 2003;47:17–26. doi: 10.1016/S1043-6618(02)00252-9. PubMed DOI
Fried M.W., Navarro V.J., Afdhal N., Belle S.H., Wahed A.S., Hawke R.L., Doo E., Meyers C.M., Reddy K.R. Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis c unsuccessfully treated with interferon therapy: A randomized controlled trial. JAMA. 2012;308:274–282. doi: 10.1001/jama.2012.8265. PubMed DOI PMC
Abenavoli L.M., Capasso R., Milic N., Capasso F. Milk thistle in liver diseases: Past, present, future. Phytother. Res. 2010;24:1423–1432. doi: 10.1002/ptr.3207. PubMed DOI
Seeff L.B., Curto T.M., Szabo G., Everson G.T., Bonkovsky H.L., Dienstag J.L., Shiffman M.L., Lindsay K.L., Lok A.S., Di Bisceglie A.M., et al. Herbal product use by persons enrolled in the hepatitis c antiviral long-term treatment against cirrhosis (halt-c) trial. Hepatology. 2008;47:605–612. doi: 10.1002/hep.22044. PubMed DOI
Féher J., Lengyel G. Silymarin in the prevention and treatment of liver diseases and primary liver cancer. Curr. Pharm. Biotechnol. 2012;13:210–217. doi: 10.2174/138920112798868818. PubMed DOI
Zhong S., Fan Y., Yan Q., Fan X., Wu B., Han Y., Zhang Y., Chen Y., Zhang H., Niu J. The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta-analysis (prisma) of randomized control trials. Medicine. 2017;96:e9061. doi: 10.1097/MD.0000000000009061. PubMed DOI PMC
Ferenci P., Scherzer T.M., Kerschner H., Rutter K., Beinhardt S., Hofer H., Schöniger–Hekele M., Holzmann H., Steindl–Munda P. Silibinin is a potent antiviral agent in patients with chronic hepatitis c not responding to pegylated interferon/ribavirin therapy. Gastroenterology. 2008;135:1561–1567. doi: 10.1053/j.gastro.2008.07.072. PubMed DOI
De Avelar C.R., Pereira E.M., Costa P.R., De Jesus R.P., De Oliveira L.P.M. Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis. World J. Gastroenterol. 2017;23:5004–5017. doi: 10.3748/wjg.v23.i27.5004. PubMed DOI PMC
Yang Z., Zhuang L., Lu Y., Xu Q., Chen X. Effects and tolerance of silymarin (milk thistle) in chronic hepatitis C virus infection patients: a meta-analysis of randomized controlled trials. BioMed. Res. Int. 2014;2014:9. doi: 10.1155/2014/941085. PubMed DOI PMC
Lee V., Goyal A., Hsu C.C., Jacobson J.S., Rodriguez R.D., Siegel A.B. Dietary supplement use among patients with hepatocellular carcinoma. Integr. Cancer Ther. 2015;14:35–41. doi: 10.1177/1534735414550038. PubMed DOI
Simanek V., Křen V., Ulrichová J., Vicar J., Cvak L. Silymarin: What is in the name…? An appeal for a change of editorial policy. Hepatology. 2000;32:442–444. doi: 10.1053/jhep.2000.9770. PubMed DOI
Fenclova M., Novakova A., Viktorova J., Jonatova P., Dzuman Z., Ruml T., Kren V., Hajslova J., Vitek L., Stranska-Zachariasova M. Poor chemical and microbiological quality of the commercial milk thistle-based dietary supplements may account for their reported unsatisfactory and non-reproducible clinical outcomes. Sci. Rep. 2019;9 doi: 10.1038/s41598-019-47250-0. PubMed DOI PMC
Zheleva-Dimitrova D., Nedialkov P., Kitanov G. Radical scavenging and antioxidant activities of methanolic extracts from Hypericum species growing in Bulgaria. Pharmacogn. Mag. 2010;6:74–78. doi: 10.4103/0973-1296.62889. PubMed DOI PMC
Zulueta A., Esteve M.J., Frígola A. ORAC and TEAC assays comparison to measure the antioxidant capacity of food products. Food Chem. 2009;114:310–316. doi: 10.1016/j.foodchem.2008.09.033. DOI
Pyrzynska K., Pękal A. Application of free radical diphenylpicrylhydrazyl (DPPH) to estimate the antioxidant capacity of food samples. Anal. Methods. 2013;5:4288–4295. doi: 10.1039/c3ay40367j. DOI
Liu S., Huang H. Assessments of antioxidant effect of black tea extract and its rationals by erythrocyte haemolysis assay, plasma oxidation assay and cellular antioxidant activity (CAA) assay. J. Funct. Foods. 2015;18:1095–1105. doi: 10.1016/j.jff.2014.08.023. DOI
Dixit N., Baboota S., Kohli K., Ahmad S., Ali J. Silymarin: A review of pharmacological aspects and bioavailability enhancement approaches. Indian J. Pharmacol. 2007;39:172–179. doi: 10.4103/0253-7613.36534. DOI
Anthony K.P., Saleh M.A. Free radical scavenging and antioxidant activities of silymarin components. Antioxidants. 2013;2:398–407. doi: 10.3390/antiox2040398. PubMed DOI PMC
Barnes P.M., Bloom B., Nahin R.L. Complementary and alternative medicine use among adults and children: United States, 2007. Natl. Health Stat. Rep. 2008;12:1–23. PubMed
Smith T., Kawa K., Eckl V., Morton C., Stredney R. Herbal supplement sales in us increase 7.7% in 2016 consumer preferences shifting toward ingredients with general wellness benefits, driving growth of adaptogens and digestive health products. Am. Bot. C. 2017;115:56–65.
Chambers C.S., Holečková V., Petrásková L., Biedermann D., Valentová K., Buchta M., Křen V. The silymarin composition… and why does it matter??? Food Res. Int. 2017;100:339–353. doi: 10.1016/j.foodres.2017.07.017. PubMed DOI
Anthony K., Saleh M.A. Chemical profiling and antioxidant activity of commercial milk thistle food supplements. J. Chem. Pharm. Res. 2012;4:4440–4450.
Fibigr J., Šatínský D., Solich P. A new approach to the rapid separation of isomeric compounds in a Silybum marianum extract using UHPLC core-shell column with F5 stationary phase. J. Pharm. Biomed. Anal. 2017;134:203–213. doi: 10.1016/j.jpba.2016.11.042. PubMed DOI
Filippopoulou K., Papaevgeniou N., Lefaki M., Paraskevopoulou A., Biedermann D., Křen V., Chondrogianni N. 2,3-Dehydrosilybin A/B as a pro-longevity and anti-aggregation compound. Free. Radic. Biol. Med. 2017;103:256–267. doi: 10.1016/j.freeradbiomed.2016.12.042. PubMed DOI
Šuk J., Jašprová J., Biedermann D., Petrásková L., Valentová K., Křen V., Muchová L., Vítek L. Isolated silymarin flavonoids increase systemic and hepatic bilirubin concentrations and lower lipoperoxidation in mice. Oxid. Med. Cell. Longev. 2019;2019:12. doi: 10.1155/2019/6026902. PubMed DOI PMC
Biedermann D., Buchta M., Holečková V., Sedlák D., Valentová K., Cvačka J., Bednárová L., Křenková A., Kuzma M., Škuta C., et al. Silychristin: Skeletal alterations and biological activities. J. Nat. Prod. 2016;79:3086–3092. doi: 10.1021/acs.jnatprod.6b00750. PubMed DOI
Hammouda F.M., Ismail S.I., Hassan N.M., Zaki A.K., Kamel A., Rimpler H. Evaluation of the silymarin content in Silybum marianum (L.) Gaertn. Cultivated under different agricultural conditions. Phytother. Res. 1993;7:90–91. doi: 10.1002/ptr.2650070122. DOI
Lobo V., Patil A., Phatak A., Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn. Rev. 2010;4:118–126. doi: 10.4103/0973-7847.70902. PubMed DOI PMC
Amorati R., Valgimigli L. Advantages and limitations of common testing methods for antioxidants. Free. Radic. Res. 2015;49:633–649. doi: 10.3109/10715762.2014.996146. PubMed DOI
Miguel-Chávez R.S. Phenolic antioxidant capacity: A review of the state of the art. In: Soto-Hernandez M., Palma-Tenango M., Garcia-Mateos M.R., editors. Phenolic Compounds—Biological Activity. IntechOpen Limited; London, UK: 2017.
Köksal E., Gulcin I., Beyza S., Sarikaya Ö., Bursal E. In vitro antioxidant activity of silymarin. J. Enzym. Inhib. Med. Chem. 2009;24:395–405. doi: 10.1080/14756360802188081. PubMed DOI
Sharifi R., Pasalar P., Kamalinejad M., Dehpour A.R., Tavangar S.M., Paknejad M., Mehrabani Natanzi M., Nourbakhsh M., Ahmadi Ashtiani H.R., Akbari M., et al. The effect of silymarin (Silybum marianum) on human skin fibroblasts in an in vitro wound healing model. Pharm. Biol. 2013;51:298–303. doi: 10.3109/13880209.2012.721789. PubMed DOI
Thaipong K., Boonprakob U., Crosby K., Cisneros-Zevallos L., Byrne D.H. Comparison of ABTS, DPPH, FRAP, and ORAC assays for estimating antioxidant activity from guava fruit extracts. J. Food Compos. Anal. 2006;19:669–675. doi: 10.1016/j.jfca.2006.01.003. DOI
Lucas-Abellán C., Mercader-Ros M.T., Zafrilla M.P., Gabaldon J.A., Núñez-Delicado E. Comparative study of different methods to measure antioxidant activity of resveratrol in the presence of cyclodextrins. Food Chem. Toxicol. 2011;49:1255–1260. doi: 10.1016/j.fct.2011.03.004. PubMed DOI
Blasa M., Angelino D., Gennari L., Ninfali P. The cellular antioxidant activity in red blood cells (CAA-RBC): A new approach to bioavailability and synergy of phytochemicals and botanical extracts. Food Chem. 2011;125:685–691. doi: 10.1016/j.foodchem.2010.09.065. DOI
Panche A.N., Diwan A.D., Chandra S.R. Flavonoids: An overview. J. Nutr. Sci. 2016;5:e47. doi: 10.1017/jns.2016.41. PubMed DOI PMC
Carbon Monoxide-Releasing Activity of Plant Flavonoids
Comparison of Chemical Composition and Biological Activities of Eight Selaginella Species
Cytoprotective Activity of Natural and Synthetic Antioxidants
In Vitro Comparison of the Bioactivities of Japanese and Bohemian Knotweed Ethanol Extracts